Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of May 14, 2025 • 2:30 AM ET

Date/Time Source News Release
05/07/2025 09:00 PM EDT GlobeNewswire Bragar Eagel & Squire, P.C. Is Investigating RobinHood, Aldeyra, Landstar, and ICU Medical and Encourages Investors to Contact the Firm
05/07/2025 08:46 AM EDT GlobeNewswire ALDX SECURITIES UPDATE: Aldeyra Therapeutics Investors with Losses may have been affected by Securities Violations - Contact BFA Law (NASDAQ:ALDX)
05/06/2025 04:42 PM EDT GlobeNewswire Aldeyra Therapeutics, Inc. (ALDX) Faces Scrutiny After Stock Drops 70% On FDA's Reproxalap Complete Response Letter - Hagens Berman
05/06/2025 07:08 AM EDT Newsfile ALDX SECURITIES INVESTIGATION: Aldeyra Therapeutics Investors are Notified to Contact BFA Law about Pending Securities Investigation
05/05/2025 06:34 PM EDT Business Wire Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Chamber Trial of Reproxalap and Plans NDA Resubmission
05/05/2025 04:00 PM EDT Business Wire Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Topline Results from Phase 3 Dry Eye Disease Clinical Trials of Reproxalap
05/04/2025 08:18 AM EDT Newsfile ALDX INQUIRY: BFA Law Notifies Aldeyra Therapeutics, Inc. Investors to Contact the Firm About Pending Investigation into the Company
05/01/2025 04:18 PM EDT GlobeNewswire Aldeyra Therapeutics, Inc. (ALDX) Faces Scrutiny After Stock Drops 70% On FDA's Reproxalap Complete Response Letter - Hagens Berman
05/01/2025 08:08 AM EDT GlobeNewswire ALDX INVESTIGATION: Aldeyra Therapeutics (NASDAQ:ALDX) Investors with Losses are Urged to Contact BFA Law about its Investigation into the Company
04/30/2025 07:36 AM EDT Newsfile ALDX NOTIFICATION: Aldeyra Therapeutics, Inc. Investors are Encouraged to Contact BFA Law about the Pending Securities Investigation
Page

Additional News

As of May 14, 2025 • 2:30 AM ET

Date/Time Source News Release
05/08/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 8th, 2025
05/08/2025 05:31 AM EDT US Earnings Reports Expected earnings - Aldeyra Therapeutics Inc.
05/06/2025 03:48 PM EDT ACCESS Newswire IA ALDX SECURITIES NEWS: Aldeyra Therapeutics, Inc. Investigation Could Allow Investors to Recover Losses; Contact BFA Law to Discuss
05/01/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 1st, 2025
05/01/2025 05:30 AM EDT US Earnings Reports Expected earnings - Aldeyra Therapeutics Inc.
04/30/2025 03:38 PM EDT ACCESS Newswire IA ALDX ANNOUNCEMENT: Aldeyra Therapeutics, Inc. Investors may have been affected by Securities Violations - Contact BFA Law
04/29/2025 04:07 PM EDT ACCESS Newswire IA ALDX NEWS: Aldeyra Therapeutics, Inc. is Being Investigated for Securities Violations - Investors are Alerted to Contact BFA Law
04/25/2025 03:22 PM EDT ACCESS Newswire IA ALDX SHAREHOLDER NEWS: Aldeyra Therapeutics, Inc. 75% Stock Plummet Leads to Securities Investigation - Investors are Urged to Contact BFA Law
04/23/2025 03:45 PM EDT ACCESS Newswire IA Aldeyra Therapeutics Investors With Significant Financial Losses Encouraged to Contact Kehoe Law Firm, P.C. - ALDX
04/23/2025 03:36 PM EDT ACCESS Newswire IA ALDX INVESTIGATION: Aldeyra Therapeutics, Inc. is being Investigated for Securities Violations - Investors are Notified to Contact BFA Law
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.